POST-COVID AND ITS GASTROINTESTINAL MANIFESTATIONS
Abstract
This article provides a review of the literature on such a relevant topic in the epidemiological situation, on the impact of COVID-19 on the digestive organs and post-covid manifestations from the gastrointestinal tract. A review of more than 15 international literature sources and metadata is presented, reliable factors about post-COVID manifestations are given. Depending on the course and duration of COVID-19, definitions of the diagnosis are presented. It also presents the multi-system nature of Post-COVID. The main purpose of this article is to review the literature and metadata from sources to assess the impact of COVID-19 on the gastrointestinal tract and the nature of post-COVID gastrointestinal manifestations. The COVID-19 pandemic has gripped millions of people around the world, leaving a global burden. Therefore, it is important to continue studying the theoretical and clinical foundations of the disease, both in the main period of the disease, and multiple organ manifestations of COVID-19, as systemic pathophysiological consequences. The main conclusion of this article can reasonably be said about the negative impact of SARS-CoV-2 on the gastrointestinal tract in the acute period, as well as the long-term effects of the virus on the gastrointestinal tract. The digestive organs, as well as the respiratory organs, are the entrance gates of the virus.
Downloads
References
Список литературы / References
Abdelmohsen M.A., Alkandari B.M., Gupta V.K., ElBeheiry A.A. Diagnostic value of abdominal sonography in confirmed Covid-19 intensive care patients. Egypt. J. Radiol. Nucl. Med., 2020, vol. 51, pp. 1–7. https://www.doi.org/10.1186/s43055-020-00317-9
Zhong P., Xu J., Yang D., Shen Y., Wang L., Feng Y., Du C., Song Y., Wu C., Hu X., et al. Covid-19-associated gastrointestinal and liver injury: Clinical features and potential mechanisms. Signal. Transduct. Target. Ther., 2020, vol. 5, 256. https://www.doi.org/10.1038/s41392-020-00373-7
Villapol S. Gastrointestinal symptoms associated with Covid-19: Impact on the gut microbiome. Transl. Res., 2020, vol. 226, pp. 57–69. https://www.doi.org/10.1016/j.trsl.2020.08.004
Dong Z.Y., Xiang B.J., Jiang M., Sun M.J., Dai C. The prevalence of gastrointestinal symptoms, abnormal liver function, digestive system disease and liver disease in Covid-19 infection: A systematic review and meta-analysis. J. Clin. Gastroenterol., 2021, vol. 55, pp. 67–76. https://www.doi.org/10.1097/MCG.0000000000001424
Wang J.G., Cui H.R., Tang H.B., Deng X.L. Gastrointestinal symptoms and fecal nucleic acid testing of children with 2019 coronavirus disease: A systematic review and meta-analysis. Sci. Rep., 2020, vol. 10, 17846. https://www.doi.org/10.1038/s41598-020-74913-0
Effenberger M., Grabherr F., Mayr L., Schwaerzler J., Nairz M., Seifert M., Hilbe R., Seiwald S., Scholl-Buergi S., Fritsche G., et al. Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut., 2020, vol. 69, pp. 1543–1544. https://www.doi.org/10.1136/gutjnl-2020-321388
Schmulson M., Ghoshal U.C., Barbara G. Managing the Inevitable Surge of Post-COVID-19 Functional Gastrointestinal Disorders. Am. J. Gastroenterol., 2021, vol. 116, pp. 4–7. https://www.doi.org/10.14309/ajg.0000000000001062
An Y.W., Song S., Li W.X., Chen Y.X., Hu X.P., Zhao J., Li Z.W., Jiang G.Y., Wang C., Wang J.C., et al. Liver function recovery of COVID-19 patients after discharge, a follow-up study. Int. J. Med. Sci., 2021, vol. 18, pp. 176–186. https://www.doi.org/10.7150/ijms.50691
Camargo S.M., Singer D., Makrides V., Huggel K., Pos K.M., Wagner K.A. et al. The tissue-specific amino acid transfer partners ACE2 and Collectrin interact differently with Hartnup mutations. Gastroenterology, 2009, vol. 136(3), pp. 872–882. https://www.doi.org/10.1053/j.gastro.2008.10.055
de Oliveira GLV, Leyte A.Z., Higuchi B.S., Gonzaga M.I., Mariano V.S. Gut dysbacteriosis and the use of probiotics in autoimmune diseases. Immunology, 2017, vol. 152(1), pp. 1–12. https://www.doi.org/10.1111/imm.12765
Bornstein S.R., Rubino F., Khunti K., Mingrone G., Hopkins D., Birkenfeld A.L. et al. . Practical guidelines for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol, 2020, vol. 8(6), pp. 546–550. https://www.doi.org/10.1016/S2213-8587(20)30152-2
de Carvalho Vidigal F, Guedes Cocate P, Goncalves Pereira L, de Cassia Goncalves Alfenas R. The role of hyperglycemia in the induction of oxidative stress and inflammation. Nutricion Hospitalaria, 2012, vol. 27(5), pp. 1391–1398. https://www.doi.org/10.3305/nh.2012.27.5.5917
Montefusco L, Ben Nasr M, D’Addio F, Loretelli S, Rossi A, Pastore I, et al. Acute and long-term impairment of glycometabolic control after SARS-Cov-2 infection. Nath Metab, 2021, vol. 3(6), pp. 774–785. https://www.doi.org/10.1038/s42255-021-00407-6
Wu HJ, Wu E. The role of the gut microbiota in immune homeostasis and autoimmunity. Gut Microbes, 2012, vol. 3(1), pp. 4–14. https://www.doi.org/10.4161/gmic.19320
Yeoh YK, Zuo T, Lui GC, Zhang F, Liu Q, Li AY, et al. . Gut microbiota composition reflects disease severity and dysfunctional immune responses in COVID-19 patients. Guth, 2021, vol. 70(4), pp. 698–706. https://www.doi.org/10.1136/gutjnl-2020-323020
Camargo S.M., Singer D., Makrides V., Huggel K., Pos K.M., Wagner K.A. et al. . The tissue-specific amino acid transfer partners ACE2 and Collectrin interact differently with Hartnup mutations. Gastroenterology, 2009, vol. 136(3), pp. 872–882. https://www.doi.org/10.1053/j.gastro.2008.10.055
Copyright (c) 2023 Lidia D. Sadretdinova, Khalida Kh. Gantseva, Anton V. Tyurin
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
